NCT07086365

Brief Summary

Feasibility of using immersive virtual functional rehabilitation for recovery of upper extremity function in patients with early-stage stroke: a pilot study

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 29, 2023

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 18, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

May 8, 2025

Completed
3 months until next milestone

First Posted

Study publicly available on registry

July 25, 2025

Completed
Last Updated

July 25, 2025

Status Verified

July 1, 2025

Enrollment Period

1.8 years

First QC Date

May 8, 2025

Last Update Submit

July 22, 2025

Conditions

Keywords

strokerehabilitationneurorehabilitation

Outcome Measures

Primary Outcomes (2)

  • System Usability Scale [SUS]

    Questionnaire completed by the handlers who administer the immersive virtual reality system

    The treatment providers fill out the questionnaire at the end of treatment. It depends of the group patient: 10 or 20-session treatment.

  • User Satisfaction Evaluation Questionnaire [USEQ]

    Questionnaire of 5 questions with 5 options based on likert rate. Is filled for the patient recruited

    Administered within the first 7 days of using the immersive virtual reality device

Secondary Outcomes (4)

  • Fugl-Meyer Assessment for Upper Extremity

    It is administered in three stages: Baseline or day 1 (pre treatment). In the week number 4 (post treatment). Up to 8 weeks (follow-up). Through study completion, an average of 6 months.

  • Motor Activity Log

    It is administered in three stages: Baseline or day 1 (pre treatment). In the week number 4 (post treatment). Up to 8 weeks (follow-up). Through study completion, an average of 6 months.

  • Box and block test

    It is administered in three stages: Baseline or day 1 (pre treatment). In the week number 4 (post treatment). Up to 8 weeks (follow-up). Through study completion, an average of 6 months.

  • Medical research council

    It is administered in three stages: Baseline or day 1 (pre treatment). In the week number 4 (post treatment). Up to 8 weeks (follow-up). Through study completion, an average of 6 months.

Study Arms (2)

10 session

OTHER

Participants receive 10 sessions of intervention with virtual inmersive reality. Virtual reality with hand tracking and immersive environment

Device: Immersive virtual reality

20 sessions

OTHER

Participants receive 20 sessions of intervention with virtual inmersive reality. Virtual reality with hand tracking and immersive environment.

Device: Immersive virtual reality

Interventions

Virtual reality with hand tracking and immersive environment

10 session20 sessions

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age \> 18 years old
  • first episode of stroke (ischemic or hemorrhagic)
  • time since stroke onset between 0 to 6 months
  • upper limb motor impairment with the National Institutes of Health Stroke Scale arm motor sub-item score between 1 and 4
  • medically stable parameters for rehabilitation initiation.

You may not qualify if:

  • Delirium diagnosed using the Confusion Assessment Method
  • Montreal Cognitive Assessment Scale \<18
  • Severe visual/perceptual deficits (spatial neglect affecting \>70% of trials or visual acuity \<20/200)
  • previous participation in virtual reality-based rehabilitation
  • inability to provide informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinica Alemana

Santiago, Santiago Metropolitan, 8340518, Chile

Location

Related Publications (2)

  • Demeco A, Zola L, Frizziero A, Martini C, Palumbo A, Foresti R, Buccino G, Costantino C. Immersive Virtual Reality in Post-Stroke Rehabilitation: A Systematic Review. Sensors (Basel). 2023 Feb 3;23(3):1712. doi: 10.3390/s23031712.

    PMID: 36772757BACKGROUND
  • Peralta-Wieland B, Vasquez-Torres R, Maldonado-Diaz M, Yoma M. Immersive Virtual Reality-Based Rehabilitation for Upper Limb Recovery in Acute and Subacute Stroke Patients: A Feasibility Study. Physiother Res Int. 2026 Jan;31(1):e70151. doi: 10.1002/pri.70151.

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: Pilot study evaluating the feasibility of using an immersive virtual reality device in patients with stroke in the acute and sub-acute stages. Preliminary functional outcomes about upper extremity function are also assessed.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Ricardo Vasquez

Study Record Dates

First Submitted

May 8, 2025

First Posted

July 25, 2025

Study Start

March 29, 2023

Primary Completion

December 30, 2024

Study Completion

March 18, 2025

Last Updated

July 25, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations